Exploring the Anti-Obesity Effects of Prebiotics and Probiotics in Rats; An Experimental Study
DOI:
https://doi.org/10.36283/PJMD13-1/005Keywords:
Gastrointestinal Microbiome, Obesity, Prebiotic, ProbioticsAbstract
Background: Excessive body fat, or obesity, poses a significant global health concern. Research has highlighted the connection between gut microbiota and obesity. This study aimed to investigate whether the administration of prebiotics and probiotics significantly contributes to controlling obesity in a rat model with induced obesity through a high-fat diet (HFD).
Methods: This experimental study involved 50 healthy male Albino Wistar Rats, aged between 10-14 weeks and weighing between 140-180 grams, whereas female rats and rats with any disease were excluded. They were divided into five groups: control (G-I), HFD alone (G-II), Prebiotic + HFD (G-III), Probiotics + HFD (G-IV), and Prebiotic + Probiotics + HFD (G-V). Data were analyzed using SPSS version 22, calculating Mean±S.D. ANOVA and post-hoc tests assessed weight changes between groups, with p-values ≤0.05 considered statistically significant.
Results: Weight changes were observed across all groups on days 0, 35, and 98. The percentages of mean weight change from day 0 to 98 were as follows: G-I, 11.08%; G-II, 47.98%; G-III, 29.88%; G-IV, 29.58%; and G-V, 20.54%. Significant differences (p<0.001) were noted among the groups.
Conclusion: Results in our study indicated that the inclusion of prebiotics and probiotics in the diet of rats following an HFD yields a beneficial outcome in terms of reduction of body weight. This positive effect is attributed to the stimulation and enhancement of the activity of beneficial gut bacteria. The synergistic interaction between prebiotics, probiotics, and the gut microbiota shows promise in mitigating obesity through targeted dietary interventions.
References
León Aguilera XE, Manzano A, Pirela D, Bermúdez V. Probiotics and Gut Microbiota in Obesity: Myths and Realities of a New Health Revolution. J Pers Med. 2022;12(8):1282. doi: 10.3390/jpm12081282.
Wiciński M, Gębalski J, Gołębiewski J, Malinowski B. Probiotics for the Treatment of Overweight and Obesity in Humans-A Review of Clinical Trials. Microorganisms. 2020;8(8):1148. doi: 10.3390/microorganisms8081148.
Asif M, Aslam M, Altaf S, Atif S, Majid A. Prevalence and Sociodemographic Factors of Overweight and Obesity among Pakistani Adults. J Obes Metab Syndr. 2020;29(1):58-66. doi: 10.7570/jomes19039.
Swanson KS, Gibson GR, Hutkins R, Reimer RA, Reid G, Verbeke K, Scott KP, Holscher HD, Azad MB, Delzenne NM, Sanders ME. The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of synbiotics. Nat Rev Gastroenterol Hepatol. 2020;17(11):687-701. doi: 10.1038/s41575-020-0344-2.
You S, Ma Y, Yan B, Pei W, Wu Q, Ding C, Huang C. The promotion mechanism of prebiotics for probiotics: A review. Front Nutr. 2022;9:1000517. doi: 10.3389/fnut.2022.1000517.
Noor J, Chaudhry A, Batool S, Noor R, Fatima G. Exploring the Impact of the Gut Microbiome on Obesity and Weight Loss: A Review Article. Cureus. 2023;15(6):e40948. doi: 10.7759/cureus.40948.
Barathikannan K, Chelliah R, Rubab M, Daliri EB, Elahi F, Kim DH, Agastian P, Oh SY, Oh DH. Gut Microbiome Modulation Based on Probiotic Application for Anti-Obesity: A Review on Efficacy and Validation. Microorganisms. 2019;7(10):456. doi: 10.3390/microorganisms7100456.
Chang CJ, Lin TL, Tsai YL, Wu TR, Lai WF, Lu CC, Lai HC. Next-generation probiotics in disease amelioration. J Food Drug Anal. 2019;27(3):615-622. doi: 10.1016/j.jfda.2018.12.011.
Roy S, Dhaneshwar S. Role of prebiotics, probiotics, and synbiotics in management of inflammatory bowel disease: Current perspectives. World J Gastroenterol. 2023; 29(14):2078-2100. doi: 10.3748/wjg.v29.i14.2078. Erratum in: World J Gastroenterol. 2023;29(35):5178-5179.
Ko MJ and Lim CY. General considerations for sample size estimation in animal study. Korean J Anesthesiol.2021;74(1):23-29. https://doi.org/10.4097/kja.20662.
Aoun A, Darwish F, Hamod N. The Influence of the Gut Microbiome on Obesity in Adults and the Role of Probiotics, Prebiotics, and Synbiotics for Weight Loss. Prev Nutr Food Sci. 2020;25(2):113-123. doi: 10.3746/pnf.2020.25.2.113.
Portincasa P, Bonfrate L, Vacca M, De Angelis M, Farella I, Lanza E, Khalil M, Wang DQ, Sperandio M, Di Ciaula A. Gut Microbiota and Short Chain Fatty Acids: Implications in Glucose Homeostasis. Int J Mol Sci. 2022;23(3):1105. doi: 10.3390/ijms23031105.
Geng J, Ni Q, Sun W, Li L, Feng X. The links between gut microbiota and obesity and obesity-related diseases, Biomedicine & Pharmacotherapy.2022;147:112678, ISSN 0753-3322, https://doi.org/10.1016/j.biopha.2022.112678.
Kaur H, Kaur G, Ali SA. Dairy-Based Probiotic-Fermented Functional Foods: An Update on Their Health-Promoting Properties. Fermentation. 2022; 8(9):425. https://doi.org/10.3390/fermentation8090425
Soltani S, Ashoori M, Dehghani F, Meshkini F, Clayton ZS, Abdollahi S. Effects of probiotic/synbiotic supplementation on body weight in patients with diabetes: a systematic review and meta-analyses of randomized controlled trials. BMC Endocr Disord. 2023;23(1):86. doi: 10.1186/s12902-023-01338-x.
Álvarez-Arraño V, Martín-Peláez S. Effects of Probiotics and Synbiotics on Weight Loss in Subjects with Overweight or Obesity: A Systhematic Review. Nutrients. 2021;13(10):3627. doi: 10.3390/nu13103627.
Lasker S, Rahman MM, Parvez F, Zamila M, Miah P, Nahar K, Kabir F, Sharmin SB, Subhan N, Ahsan GU, Alam MA. High-fat diet-induced metabolic syndrome and oxidative stress in obese rats are ameliorated by yogurt supplementation. Sci Rep. 2019;9(1):20026. doi: 10.1038/s41598-019-56538-0.
Ben Othman R, Ben Amor N, Mahjoub F, Berriche O, El Ghali C, Gamoudi A, Jamoussi H. A clinical trial about effects of prebiotic and probiotic supplementation on weight loss, psychological profile, and metabolic parameters in obese subjects. Endocrinol Diabetes Metab. 2023;6(2):e402. doi: 10.1002/edm2.402.
Chen J, Chen X, Ho CL. Recent Development of Probiotic Bifidobacteria for Treating Human Diseases. Front Bioeng Biotechnol. 2021;9:770248. doi: 10.3389/fbioe.2021.770248.
Weninger, S.N., Herman, C., Meyer, R.K. et al. Oligofructose improves small intestinal lipid-sensing mechanisms via alterations to the small intestinal microbiota. Microbiome.2023; 11(169). https://doi.org/10.1186/s40168-023-01590-2
Wang B, Wang L, Wang H, Dai H, Lu X, Lee Y-K, Gu Z, Zhao J, Zhang H, Chen W, Wang G. Targeting the Gut Microbiota for Remediating Obesity and Related Metabolic Disorders.
The Journal of Nutrition.2021;151(7):1703-1716. https://doi.org/10.1093/jn/nxab103.
Paone P, Suriano F, Jian C, Korpela K, Delzenne NM, Van Hul M, Salonen A, Cani PD. Prebiotic oligofructose protects against high-fat diet-induced obesity by changing the gut microbiota, intestinal mucus production, glycosylation and secretion. Gut Microbes. 2022;14(1):2152307. doi: 10.1080/19490976.2022.2152307.
Chaiyasut C, Sivamaruthi BS, Kesika P, Khongtan S, Khampithum N, Thangaleela S, Peerajan S, Bumrungpert A, Chaiyasut K, Sirilun S, Sittiprapaporn P. Synbiotic Supplementation Improves Obesity Index and Metabolic Biomarkers in Thai Obese Adults: A Randomized Clinical Trial. Foods. 2021;10(7):1580. doi: 10.3390/foods10071580.
Borka Balas R, Meliț LE, Lupu A, Lupu VV, Mărginean CO. Prebiotics, Probiotics, and Synbiotics-A Research Hotspot for Pediatric Obesity. Microorganisms. 2023;11(11):2651. doi: 10.3390/microorganisms11112651.
Berding K, Vlckova K, Marx W, Schellekens H, Stanton C, Clarke G, Jacka F, Dinan TG, Cryan JF. Diet and the Microbiota-Gut-Brain Axis: Sowing the Seeds of Good Mental Health. Adv Nutr. 2021;12(4):1239-1285. doi: 10.1093/advances/nmaa181.
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Pakistan Journal of Medicine and Dentistry
This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an open-access article distributed under the terms of the CreativeCommons Attribution License (CC BY) 4.0 https://creativecommons.org/licenses/by/4.0/
